SustiNet Board of Directors

SustiNet Board of DirectorsDecember 2, 2010 Part II – Possible additional questions for board discussionNote: this is not an exhaustive list of issues the board will need to address in the future, but it includes some topics about which the board might wish to make legislative recommendations for action in 2011

Outstanding questions: governance and administration (1 of 2)

• What additional representation should be added to the board? Stakeholder groups? Specific expertise? Elected or appointed officials (e.g. Comptroller or DSS

Commissioner)?

• Who should appoint additional board members?• What advisory committees should be established?

AC/TFs recommended: PCMH coordinating council, Health Care Quality, Health Care Safety, Preventive Health, Health Disparities & Equity, HIT Coordination

• How much of this should be spelled out in statute? How much left to the discretion of the Board?

2

Outstanding questions: governance and administration (2 of 2)• If SustiNet is administered by a quasi-governmental

agency, which rules (if any) that ordinarily apply to state agencies should also apply to SustiNet? What other rules (if any) should apply?

• What kind of staffing should SustiNet have? • Should the Board have authority to hire an Executive

Director for the SustiNet Plan? Should the Board have a role in hiring other administrative leadership?

3

Outstanding questions: operations and implementation• Should the SustiNet Plan be authorized to use one or

more third-party administrators? If so, on what terms?• Should the Board be required or authorized to take

steps for SustiNet to become licensed? • Board members agree the SustiNet plan should be

required to implement multi-year campaigns to achieve measurable, specific goals related to racial and ethnic disparities, chronic illness, wellness, health care costs, etc. Should the Board adopt other key metrics to assess progress?

4

Outstanding issues: benefit design and delivery system reform

• Does the Board need any additional authority to implement benefit design changes or delivery system reforms that will slow cost growth and improve care delivery? Should particular reforms be prioritized? How much flexibility should the Board have to respond to changing evidence?

• Are other state law changes needed to facilitate delivery system reforms? Example: a safe harbor from malpractice liability for following

approved clinical guidelines

5